Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

British Columbia Cancer Agency · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
metastatic castration-resistant prostatic cancer, poor prognosis, castrate-resistant prostate cancer, cabazitaxel, abiraterone, enzalutamide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993502
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.